What's New

Last Posted: Jun 14, 2024

• Single-cell landscape reveals the immune heterogeneity of bone marrow involvement in peripheral T-cell lymphoma.
  Jun Liu, et al. Cancer science 2024 0
• Clonal hematopoiesis and bone marrow infiltration in patients with follicular helper T-cell lymphoma of angioimmunoblastic type.
  Lennart Harland, et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2024 0 100519
• [Mutation characteristics of angioimmunoblastic T-cell lymphoma: an analysis of 75 cases].
  X Shen, et al. Zhonghua bing li xue za zhi = Chinese journal of pathology 2024 0 (1) 29-33
• Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling.
  Chunlan Zhang, et al. British journal of haematology 2023 0
• Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing.
  Dupuy Aurélie, et al. The Journal of molecular diagnostics : JMD 2018 0 (5) 677-685
• A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification.
  Fernandez-Pol Sebastian, et al. Applied immunohistochemistry & molecular morphology : AIMM 2018 0 (6) 416-422
• Angioimmunoblastic T-cell lymphoma in Taiwan reveals worse progression-free survival for RHOA G17V mutated subtype.
  Hsu Ya-Ting, et al. Leukemia & lymphoma 2019 0 (5) 1108-1118
• Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma.
  Tanzima Nuhat Sharna, et al. Cancer science 2018 0 (5) 1682-1689
• [Angioimmunoblastic T-cell lymphoma: histopathological grading and prognosis].
  Guo Y M, et al. Zhonghua bing li xue za zhi = Chinese journal of pathology 2019 0 (10) 784-790
• The pathological features of angioimmunoblastic T-cell lymphomas with IDH2 mutations.
  Steinhilber Julia, et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2019 0 (8) 1123-1134
• Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial.
  Yhim H-Y, et al. Annals of oncology : official journal of the European Society for Medical Oncology 2020 0 (4) 552-559
• Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms.
  Lewis Natasha E, et al. Blood advances 2020 0 (10) 2261-2271
• RHOA mutation in follicular T-cell lymphoma: Clinicopathological analysis of 16 cases.
  Miyoshi Hiroaki, et al. Pathology international 2020 0 (9) 653-660
• A computational in silico approach to predict high-risk coding and non-coding SNPs of human PLCG1 gene.
  Khan Safayat Mahmud, et al. PloS one 2021 0 (11) e0260054
• Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking.
  Cheng Shuhua, et al. eLife 2021 0
• Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.
  Pastoret Cédric, et al. Blood 2021 0 (23) 3237-3250
• Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing.
  Hou Yue, et al. Molecular carcinogenesis 2022 0 (2) 200-209
• Comparison of Epstein-Barr virus-positive mucocutaneous ulcer associated with treated lymphoma or methotrexate in Japan.
  Daroontum Teerada, et al. Histopathology 2018 0 (7) 1115-1127
• TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
  de Pádua Covas Lage Luís Alberto, et al. Cancer biomarkers : section A of Disease markers 2022 9
• Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas.
  Kim Seok Jin, et al. Cancer research and treatment 2022 3
• Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers.
  Mihashi Yasuhito, et al. Diagnostic pathology 2021 11 (1) 101
• Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas.
  Ye Yingying, et al. Experimental hematology & oncology 2021 2 (1) 9
• Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma.
  Lemonnier François, et al. Blood advances 2021 1 (2) 539-548
• Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma.
  Ottolini Barbara, et al. Blood advances 2020 6 (11) 2392-2403
• Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma.
  Zing Natalia Pin Chuen et al. Oncology (Williston Park, N.Y.) 2018 Aug 32(8)
• Candidate susceptibility variants in angioimmunoblastic T-cell lymphoma.
  Donner Iikki, et al. Familial cancer 2018 8
• A Clinicopathologic Study of Lennert Lymphoma and Possible Prognostic Factors: The Importance of Follicular Helper T-cell Markers and the Association With Angioimmunoblastic T-cell Lymphoma.
  Kurita Daisuke, et al. The American journal of surgical pathology 2016 7
• Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
  Vallois David, et al. Blood 2016 7
• Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma.
  Saillard Colombe, et al. Hematological oncology 2016 6
• Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.
  Ondrejka Sarah L, et al. The American journal of surgical pathology 2015 11
• A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
  Odejide Oreofe, et al. Blood 2014 2 (9) 1293-6
• Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.
  Lemonnier François, et al. Blood 2012 8 (7) 1466-9
• IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.
  Cairns Rob A, et al. Blood 2012 2 (8) 1901-3
• Angioimmunoblastic T-cell lymphoma
  From NCATS Genetic and Rare Diseases Information Center
• Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas.
  Bonzheim Irina, et al. Journal of hematopathology 2008 7 (1) 11-21